KORU Medical CCO buys 32K shares at $3.16
Rhea-AI Filing Summary
KORU Medical Systems, Inc. (KRMD) reported that its Chief Commercial Officer, Adam R. Kalbermatten, purchased 32,000 shares of common stock on September 8, 2026, in an open-market or private transaction at $3.16 per share, bringing his directly held stake to 394,017 shares. The filing indicates this trade was not made pursuant to a Rule 10b5-1 trading plan, and it includes a standard disclaimer that the reporting person is not admitting beneficial ownership beyond what is required.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 32,000 shares
Net Buy
1 txn
Insider
KALBERMATTEN ADAM R
Role
Chief Commercial Officer
Bought
32,000 shs ($101K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 32,000 | $3.16 | $101K |
Holdings After Transaction:
Common Stock — 394,017 shares (Direct)
Key Figures
Shares purchased: 32,000 shares
Purchase price per share: $3.16 per share
Shares held after transaction: 394,017 shares
+1 more
4 metrics
Shares purchased
32,000 shares
Common stock purchased on September 8, 2026 by the Chief Commercial Officer
Purchase price per share
$3.16 per share
Average price for 32,000 KRMD common shares bought on September 8, 2026
Shares held after transaction
394,017 shares
Directly owned KRMD common stock by the Chief Commercial Officer following the purchase
Net shares bought in filing
32,000 shares
Net change in shareholdings reported in this Form 4
Key Terms
beneficial owner, Power of Attorney, Section 16 of the Securities Exchange Act of 1934, Rule 10b5-1 trading plan
4 terms
beneficial owner regulatory
"the beneficial owner of any equity securities covered by this statement"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
Power of Attorney regulatory
"Power of Attorney has been previously filed."
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
Section 16 of the Securities Exchange Act of 1934 regulatory
"for the purposes of Section 16 of the Securities Exchange Act of 1934"
A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.
Rule 10b5-1 trading plan regulatory
"The filing indicates this trade was not made pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did KRMD report for Adam R. Kalbermatten?
KRMD reported that Chief Commercial Officer Adam R. Kalbermatten purchased 32,000 shares of common stock on September 8, 2026, in an open-market or private transaction at $3.16 per share, increasing his directly held position to 394,017 shares.
Was the KRMD insider trade made under a Rule 10b5-1 plan?
The filing states that the reported trade by KRMD’s Chief Commercial Officer on September 8, 2026 was not made pursuant to a Rule 10b5-1 trading plan.
What type of transaction did the KRMD Form 4 report?
The KRMD Form 4 reports a purchase of common stock by Chief Commercial Officer Adam R. Kalbermatten, describing it as a purchase in an open-market or private transaction of 32,000 shares at $3.16 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
